Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-γ Activation

被引:183
作者
Jacob, Asha [1 ,2 ,3 ]
Wu, Rongqian [1 ,2 ,3 ]
Zhou, Mian [1 ,2 ,3 ]
Wang, Ping [1 ,2 ,3 ]
机构
[1] N Shore Univ Hosp, Div Surg Res, Manhasset, NY 11030 USA
[2] Long Isl Jewish Med Ctr, Manhasset, NY 11030 USA
[3] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA
关键词
D O I
10.1155/2007/89369
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Curcumin, the phytochemical component in turmeric, is used as a dietary spice and a topical ointment for the treatment of inflammation in India for centuries. Curcumin (diferuloylmethane) is relatively insoluble in water, but dissolves in acetone, dimethylsulphoxide, and ethanol. Commercial grade curcumin contains 10-20% curcuminoids, desmethoxycurcumin, and bis-desmethoxycurcumin and they are as effective as pure curcumin. Based on a number of clinical studies in carcinogenesis, a daily oral dose of 3.6 g curcumin has been efficacious for colorectal cancer and advocates its advancement into Phase II clinical studies. In addition to the anticancer effects, curcumin has been effective against a variety of disease conditions in both in vitro and in vivo preclinical studies. The present review highlights the importance of curcumin as an anti-inflammatory agent and suggests that the beneficial effect of curcumin is mediated by the upregulation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation. Copyright (c) 2007 Asha Jacob et al.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock
    Abdelrahman, M
    Sivarajah, A
    Thiemermann, C
    [J]. CARDIOVASCULAR RESEARCH, 2005, 65 (04) : 772 - 781
  • [2] The peroxisome proliferator-activated receptor-γ ligand 15-deoxyΔ12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock
    Abdelrahman, M
    Collin, M
    Thiemermann, C
    [J]. SHOCK, 2004, 22 (06): : 555 - 561
  • [3] Aggarwal BB, 2003, ANTICANCER RES, V23, P363
  • [4] PHARMACOLOGY OF CURCUMA-LONGA
    AMMON, HPT
    WAHL, MA
    [J]. PLANTA MEDICA, 1991, 57 (01) : 1 - 7
  • [5] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [6] Curcumin is an in vivo inhibitor of angiogenesis
    Arbiser, JL
    Klauber, N
    Rohan, R
    van Leeuwen, R
    Huang, MT
    Fisher, C
    Flynn, E
    Byers, HR
    [J]. MOLECULAR MEDICINE, 1998, 4 (06) : 376 - 383
  • [7] Shock-induced neutrophil mediated priming for acute lung injury in mice - Divergent effects of TLR-4 and TLR-4/FasL deficiency
    Ayala, A
    Chung, CS
    Lomas, JL
    Song, GY
    Doughty, LA
    Gregory, SH
    Cioffi, WG
    LeBlanc, BW
    Reichner, J
    Simms, HH
    Grutkoski, PS
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (06) : 2283 - 2294
  • [8] Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF-κβ
    Chen, F
    Wang, MC
    O'Connor, JP
    He, M
    Tripathi, T
    Harrison, LE
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (04) : 732 - 744
  • [9] Cheng AL, 2001, ANTICANCER RES, V21, P2895
  • [10] Role of peroxisome proliferator-activated receptor-γ in the protection afforded by 15-deoxyΔ12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin
    Collin, M
    Patel, NSA
    Dugo, L
    Thiemermann, C
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (03) : 826 - 831